Meningococcal meningitis is a rare but potentially fatal bacterial infection. Permanent brain damage, hearing loss, learning disability, limb amputation, kidney failure, or death can result from the infection. Between 100 and 125 cases occur on college campuses every year. 5 to 15 college students die each year as a result. Certain college students, particularly freshmen who live or plan to live in residence halls, have a 6-fold increased risk of disease.
There is a vaccine available that is 85% to 100% effective in preventing four kinds of bacteria (serogroups A, C,Y, W-135) that cause about 70% of the disease in the United States. For additional information read the Vaccine Information Statement below.
Central Michigan University Health Services recommends that students, especially those who plan to live in the residence halls, consider receiving meningococcal meningitis vaccine. Other undergraduate students wishing to reduce their risk of meningitis can also choose to be vaccinated. New guidelines from the Centers for Disease Control (CDC) suggests that a booster vaccine might be recommended for some individuals. Contact your local health care provider or University Health Services for more information.
For additional information about meningococcal meningitis and meningitis vaccine, call University Health Services at (989) 774-6591.